Inventor
Dennis VERZIJL
Inventor
NL
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07KPeptides29%
G01NInvestigating or analysing materials by determining their chemical or physical properties10%
C12NMicroorganisms or enzymes5%
PatentTitleYear
12,589,150Antibodies binding AXL202612,570,751Binding agents binding to PD-L1 and CD137 and use thereof202612,410,258Antibodies capable of binding to OX40, variants thereof and uses thereof202511,970,544Antibodies202411,459,395Binding agents binding to PD-L1 and CD137 and use thereof202211,261,254Antibodies2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to GENMAB AS (6)· patent assignee history
2022–2026Patents assigned to BioNTech SE (3)· patent assignee history
2022–2026Based in NL· patent location history
2025Patents assigned to GANMAB AS (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GENMAB AS | 6 | 2022–2026 |
| BioNTech SE | 3 | 2022–2026 |
| GANMAB AS | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| NL | 6 | 2022–2026 |